Results 51 to 60 of about 84,613 (217)
Nuclear Medicine Status in Egypt: Our Beginnings and Where We Are Now . [PDF]
Egyptian Journal of Nuclear MedicineNuclear medicine began to take shape in the early 20th century with the discovery of radioactivity and has since grown into a crucial important medical specialty that uses radioisotopes for imaging, diagnosis, and treatment in health care [1].
Mai Elahmadawy, Hosna Moustafa
doaj +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Molecular Oncology, EarlyView.Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
The survey and analysis of clinical nuclear medicine talents training in Shanghai
肿瘤影像学, 2021 Shanghai Nuclear Society conducted a questionnaire survey on the department of nuclear medicine in thirty hospitals in 2019 to investigate the status of the application of clinical nuclear medicine and the problems in talents training in Shanghai.
XING Yan +4 more
doaj
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Molecular Oncology, EarlyView.Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Zhongguo aizheng zazhi177Lu-labeled prostate-specific membrane antigen radioligand therapy (177Lu-PSMA-RLT) is an innovative treatment approach that precisely delivers β radiation emitted by 177Lu to prostate cancer cells, causing radiation damage to the tumor cells’ DNA and ...
Nuclear Medicine Committee of China Anti-Cancer Association Cancer +1 more
doaj
Melanoma & nuclear medicine: new insights & advances
Melanoma Management, 2018 The contribution of nuclear medicine to management of melanoma patients is increasing. In intermediate-thickness N0 melanomas, lymphoscintigraphy provides a roadmap for sentinel node biopsy.
Andrés Perissinotti +4 more
doaj +1 more source
Molecular Oncology, EarlyView.Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Nuclear Medicine Infection [PDF]
Journal of Nuclear Medicine Technology, 2013 TO THE EDITOR: Nuclear medicine has come a long way in the reduction of nosocomial infections, but the truth is that there is still more we can do as a community to better ensure the safety of our patients.
openaire +2 more sources
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source